Complete News World

Prostate cancer cases are expected to double by 2040, study suggests – Science & Health

Prostate cancer cases are expected to double by 2040, study suggests – Science & Health

The number of men diagnosed with prostate cancer in the world is expected to double by 2040, meaning there will be 2.9 million new patients annually. Currently, prostate cancer is the most common form of male cancer in more than a hundred countries.

This information is provided by A Stady Which states that the number of annual deaths is expected to increase by 85%. Population aging due to the increase in life expectancy is the main reason for the increase predicted by scientists. Especially since major risk factors, such as being 50 years old and having a family history, become inevitable.

In 2020, 1.4 million cases were diagnosed worldwide, and in 2040 it is expected that 2.9 million cases will be diagnosed, meaning that about 330 men will be informed that they have the disease every hour.

The lack of data for developing countries leads experts to believe that the real numbers could be more alarming, especially with regard to the number of deaths expected to reach 700,000 in 2040.

Experts do not believe that these increases can be prevented through lifestyle changes alone, although they acknowledge that increased awareness of the disease, early diagnosis and advances in treatments can have an impact on the growth of the disease.

Nick James, lead author of the study, said: “Evidence-based interventions, such as improving early detection and education programmes, will help save lives and prevent health problems from prostate cancer in the years to come.”

Among the main symptoms of this cancer are the need to urinate frequently, especially at night, difficulty starting to urinate, the feeling of being unable to completely empty the bladder and blood loss through urine.

See also  MDB President Balea Rossi calls on Bolsonaro to veto the absurdity of the USP-Saúde vaccine budget

This data was published in the scientific journal lancet, It will be presented and discussed at the annual congress of the European Association of Urology, which is being held on Saturday.

Related articles